We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$155M
AUM Growth
-$60.5M
Cap. Flow
+$5.8M
Cap. Flow %
3.73%
Top 10 Hldgs %
75.53%
Holding
36
New
Increased
3
Reduced
3
Closed
1

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$912K
2
HOOK
HOOKIPA Pharma
HOOK
+$164K
3
IRD
Opus Genetics
IRD
+$115K

Sector Composition

Rank Sector Weight
1 Healthcare 71.85%
2 Materials 16.98%
3 Industrials 1.73%
4 Consumer Staples 1.33%
5 Financials 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MREO
26
Mereo BioPharma
MREO
$47.3M
$912K 0.59%
260,470
DEO icon
27
Diageo
DEO
$53.6B
$858K 0.55%
6,750
AGI icon
28
Alamos Gold
AGI
$13.9B
$756K 0.49%
41,000
WPM icon
29
Wheaton Precious Metals
WPM
$60.9B
$703K 0.45%
12,500
NEWP
30
New Pacific Metals
NEWP
$1.17B
$572K 0.37%
485,000
SILV
31
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$546K 0.35%
60,000
CRDL
32
Cardiol Therapeutics
CRDL
$164M
$128K 0.08%
100,000
GRAL
33
GRAIL Inc
GRAL
$3.1B
$1.78K ﹤0.01%
100
IRD
34
Opus Genetics
IRD
$302M
$53 ﹤0.01%
45
-99,955
-100% -$115K
CVS icon
35
CVS Health
CVS
$122B
-14,500
Closed -$912K

Similar funds

Knoll Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Knoll Capital Management held 36 positions worth $155M, down 28% from $216M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Knoll Capital Management deployed $5.8M of net new capital in Q4 2024, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 74% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was HOOKIPA Pharma, an estimated $164K trimmed.

  • Knoll Capital Management added most to Entera Bio in Q4 2024, an estimated $3.73M increase.
  • Knoll Capital Management's biggest Q4 2024 reduction was HOOKIPA Pharma, cutting an estimated $164K.
  • Knoll Capital Management fully exited CVS Health in Q4 2024, selling an estimated $912K.
  • Knoll Capital Management's ten largest holdings make up 76% of its $155M portfolio in Q4 2024.
  • Knoll Capital Management opened 0 new positions and closed 1 in Q4 2024.
  • Knoll Capital Management's portfolio value fell 28% quarter-over-quarter to $155M.

Based on Knoll Capital Management's 13F filing for Q4 2024, filed 18 Feb 2025.